Edward Cox

6.9k total citations
25 papers, 508 citations indexed

About

Edward Cox is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, Edward Cox has authored 25 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 6 papers in Public Health, Environmental and Occupational Health and 5 papers in Infectious Diseases. Recurrent topics in Edward Cox's work include Viral Infections and Outbreaks Research (3 papers), Antibiotic Use and Resistance (3 papers) and Lipoproteins and Cardiovascular Health (3 papers). Edward Cox is often cited by papers focused on Viral Infections and Outbreaks Research (3 papers), Antibiotic Use and Resistance (3 papers) and Lipoproteins and Cardiovascular Health (3 papers). Edward Cox collaborates with scholars based in United Kingdom, United States and Australia. Edward Cox's co-authors include Debra Birnkrant, Luciana Borio, John Farley, Robert Temple, Sumathi Nambiar, Joseph Toerner, Nicole Lurie, Michael Lanthier, Nicole M. Mahoney and Mark Sculpher and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Edward Cox

25 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward Cox United Kingdom 12 173 121 95 57 51 25 508
Kentaro Iwata Japan 12 181 1.0× 135 1.1× 53 0.6× 41 0.7× 67 1.3× 56 622
Giorgio Graziano Italy 11 153 0.9× 157 1.3× 46 0.5× 54 0.9× 22 0.4× 35 422
Stacy G. Beal United States 14 232 1.3× 234 1.9× 47 0.5× 95 1.7× 17 0.3× 41 627
Lawson Ung United States 15 148 0.9× 57 0.5× 125 1.3× 214 3.8× 42 0.8× 30 952
Padam Singh India 15 144 0.8× 176 1.5× 72 0.8× 68 1.2× 69 1.4× 41 743
Hai Thanh Le Vietnam 13 92 0.5× 75 0.6× 96 1.0× 40 0.7× 39 0.8× 27 543
Min Lv China 14 648 3.7× 129 1.1× 89 0.9× 30 0.5× 62 1.2× 57 897
Angela Huang United States 12 298 1.7× 192 1.6× 35 0.4× 165 2.9× 21 0.4× 36 778
Sarah Warner United States 14 187 1.1× 273 2.3× 220 2.3× 94 1.6× 23 0.5× 33 933
Nader Nemr Egypt 14 140 0.8× 56 0.5× 101 1.1× 31 0.5× 20 0.4× 36 486

Countries citing papers authored by Edward Cox

Since Specialization
Citations

This map shows the geographic impact of Edward Cox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Cox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Cox more than expected).

Fields of papers citing papers by Edward Cox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Cox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Cox. The network helps show where Edward Cox may publish in the future.

Co-authorship network of co-authors of Edward Cox

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Cox. A scholar is included among the top collaborators of Edward Cox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Cox. Edward Cox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cox, Edward, Rita Faria, Pedro Saramago, et al.. (2024). Challenges and opportunities for identifying people with familial hypercholesterolemia in the UK: Evidence from the National FH PASS database. Journal of clinical lipidology. 18(6). e1046–e1054. 2 indexed citations
2.
Cox, Edward, Ros Wade, Robert Hodgson, et al.. (2024). Devices for remote continuous monitoring of people with Parkinson’s disease: a systematic review and cost-effectiveness analysis. Health Technology Assessment. 28(30). 1–187. 2 indexed citations
3.
Edwardson, Charlotte L., Benjamin D. Maylor, Stuart Biddle, et al.. (2023). A multicomponent intervention to reduce daily sitting time in office workers: the SMART Work & Life three-arm cluster RCT. SHILAP Revista de lepidopterología. 11(6). 1–229. 6 indexed citations
4.
Qureshi, Nadeem, Beth Woods, Rita Faria, et al.. (2023). Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis. Health Technology Assessment. 27(16). 1–140. 2 indexed citations
5.
Faria, Rita, Pedro Saramago, Edward Cox, et al.. (2022). How does cholesterol burden change the case for investing in familial hypercholesterolaemia? A cost-effectiveness analysis. Atherosclerosis. 367. 40–47. 3 indexed citations
6.
Bywater, Tracey, Vashti Berry, Sarah Blower, et al.. (2022). A randomized controlled trial of a proportionate universal parenting program delivery model (E-SEE Steps) to enhance child social-emotional wellbeing. PLoS ONE. 17(4). e0265200–e0265200. 6 indexed citations
7.
Cox, Edward, Simon Walker, Sarah Blower, et al.. (2022). The cost-effectiveness of a proportionate parenting programme for primary caregivers and their child: an economic evaluation using evidence from the E-SEE Trial. BMC Health Services Research. 22(1). 814–814. 2 indexed citations
8.
Walker, Simon, Edward Cox, Colin Berry, et al.. (2020). Cost-effectiveness of cardiovascular imaging for stable coronary heart disease. Heart. 107(5). 381–388. 19 indexed citations
9.
Bart, Stephen M., et al.. (2020). Geographic Shifts in Antibacterial Drug Clinical Trial Enrollment: Implications for Generalizability. Clinical Infectious Diseases. 72(8). 1422–1428. 7 indexed citations
10.
11.
Cox, Edward, Pedro Saramago, John D. Kelly, et al.. (2019). Effects of Bladder Cancer on UK Healthcare Costs and Patient Health-Related Quality of Life: Evidence From the BOXIT Trial. Clinical Genitourinary Cancer. 18(4). e418–e442. 27 indexed citations
12.
South, Emily, Edward Cox, Nick Meader, Nerys Woolacott, & Susan Griffin. (2018). Strimvelis® for Treating Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency: An Evidence Review Group Perspective of a NICE Highly Specialised Technology Evaluation. PharmacoEconomics - Open. 3(2). 151–161. 20 indexed citations
13.
Filoteo, J. Vincent, et al.. (2018). Evaluation of ReminX as a Behavioral Intervention for Mild to Moderate Dementia. PubMed. 2018. 3314–3317. 13 indexed citations
14.
Russek‐Cohen, Estelle, et al.. (2016). A US Food and Drug Administration perspective on evaluating medical products for Ebola. Clinical Trials. 13(1). 105–109. 6 indexed citations
15.
Borio, Luciana, Edward Cox, & Nicole Lurie. (2015). Combating Emerging Threats — Accelerating the Availability of Medical Therapies. New England Journal of Medicine. 373(11). 993–995. 20 indexed citations
16.
Nambiar, Sumathi, et al.. (2014). Antibacterial Drug Development: Challenges, Recent Developments, and Future Considerations. Clinical Pharmacology & Therapeutics. 96(2). 147–149. 43 indexed citations
17.
Cox, Edward, Luciana Borio, & Robert Temple. (2014). Evaluating Ebola Therapies — The Case for RCTs. New England Journal of Medicine. 371(25). 2350–2351. 46 indexed citations
18.
Birnkrant, Debra & Edward Cox. (2009). The Emergency Use Authorization of Peramivir for Treatment of 2009 H1N1 Influenza. New England Journal of Medicine. 361(23). 2204–2207. 152 indexed citations
19.
Higgins, Karen M., et al.. (2008). Overview of Recent Studies of Community‐Acquired Pneumonia. Clinical Infectious Diseases. 47(S3). S150–S156. 12 indexed citations
20.
Uhl, Kathleen, et al.. (2006). Thalidomide Use in the US. Drug Safety. 29(4). 321–329. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kentaro Iwata Breakdown of academic impact, for papers by Giorgio Graziano Breakdown of academic impact, for papers by Stacy G. Beal Breakdown of academic impact, for papers by Lawson Ung Breakdown of academic impact, for papers by Padam Singh Breakdown of academic impact, for papers by Hai Thanh Le Breakdown of academic impact, for papers by Min Lv Breakdown of academic impact, for papers by Angela Huang Breakdown of academic impact, for papers by Sarah Warner Breakdown of academic impact, for papers by Nader Nemr
Rankless by CCL
2026